Orient Pharma Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	587.6	84.5	83.32	76.43	130.92
Short-Term Investments	39.8	24.8	29.8	20.8	20.8
Cash & Short-Term Investments	627.4	109.3	113.12	97.23	151.72
Cash Growth	474.04%	-3.38%	16.34%	-35.92%	-20.30%
Accounts Receivable	248.52	278.18	179.31	69.39	63.09
Other Receivables	16.38	10.36	8.16	12.91	16.82
Receivables	264.89	288.54	187.47	82.3	79.9
Inventory	322.39	279.56	233.97	194.18	156.88
Prepaid Expenses	26.46	44.12	58	39.18	30.91
Other Current Assets	18	6.91	29.7	10.24	19.89
Total Current Assets	1,259	728.43	622.25	423.12	439.31
Property, Plant & Equipment	835.58	891.83	944.96	903.28	769.71
Long-Term Investments	12.83	13.65	1.88	3.05	1.75
Other Intangible Assets	414.87	471.83	532.66	11.9	13.75
Long-Term Deferred Tax Assets	362.29	397.98	451.46	452.04	439.2
Other Long-Term Assets	53.65	16.87	9.47	54.18	100.1
Total Assets	2,938	2,521	2,563	1,848	1,764
Accounts Payable	62.07	36.14	55.57	61.97	19.6
Accrued Expenses	-	69.82	62.04	53.5	59.07
Short-Term Debt	-	250	314.5	68.5	161.5
Current Portion of Long-Term Debt	2.55	40	60.71	24.08	23.83
Current Portion of Leases	16.14	18.44	17.95	14.92	8.22
Current Unearned Revenue	4.47	64.51	22.01	64.87	78.07
Other Current Liabilities	101.88	8.35	30.56	63.22	69.17
Total Current Liabilities	187.1	487.25	563.35	351.06	419.46
Long-Term Debt	-	42.1	112.06	178.79	111.8
Long-Term Leases	179.81	195.95	211.67	221.86	109.67
Pension & Post-Retirement Benefits	-	5.86	5.09	5.94	6.85
Long-Term Deferred Tax Liabilities	1.15	1.84	-	-	0.13
Other Long-Term Liabilities	6.81	-	-	-	-
Total Liabilities	374.88	733	892.18	757.65	647.9
Common Stock	2,430	2,230	2,230	1,870	1,870
Additional Paid-In Capital	369.05	1,130	1,130	932.15	932.15
Retained Earnings	-241.01	-1,579	-1,686	-1,709	-1,682
Comprehensive Income & Other	5.08	6.05	-3.83	-2.89	-4.6
Shareholders' Equity	2,563	1,788	1,670	1,090	1,116
Total Liabilities & Equity	2,938	2,521	2,563	1,848	1,764
Total Debt	198.5	546.49	716.9	508.15	415.01
Net Cash (Debt)	428.9	-437.19	-603.78	-410.92	-263.29
Net Cash Per Share	1.85	-1.96	-2.71	-2.20	-1.41
Filing Date Shares Outstanding	247.84	223.04	223.04	187	187
Total Common Shares Outstanding	247.84	223.04	223.04	187	187
Working Capital	1,072	241.18	58.9	72.07	19.86
Book Value Per Share	10.34	8.01	7.49	5.83	5.97
Tangible Book Value	2,149	1,316	1,138	1,078	1,102
Tangible Book Value Per Share	8.67	5.90	5.10	5.76	5.89
Buildings	-	794.16	786.78	744.9	682.91
Machinery	-	439.37	430.96	367.95	361.11

Source: S&P Global Market Intelligence. Standard template. Financial Sources.